DYRK2 Anticorps
(Dual-Specificity tyrosine-(Y)-phosphorylation Regulated Kinase 2 (DYRK2))
Choisissez l’un des 61 anticorps DYRK2 de notre liste de produits basés sur 8 publications et 26 images de validation.
Découvrez des anticorps DYRK2 fiables issus d’une large sélection de fabricants renommés. Notre portefeuille permet une détection précise de DYRK2 dans plusieurs espèces, y compris Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit, Pig, Zebrafish (Danio rerio), Bat, Chicken, Monkey, Xenopus laevis, et prend en charge diverses applications de recherche telles que WB, ELISA, IHC, IF (cc), IF (p).
Trouvez rapidement l’anticorps adapté grâce à nos outils de recherche, de filtrage et de comparaison. Chaque page produit fournit des données de validation détaillées, des références bibliographiques et des retours d’utilisateurs. Contrairement aux ressources dédiées uniquement à la comparaison, vous pouvez acheter directement les anticorps sur notre site. Choisissez parmi des anticorps polyclonaux, monoclonaux ou recombinants DYRK2, issus de différents hôtes tels que Rabbit, Mouse. Parcourez nos produits ci-dessous et commandez directement pour soutenir vos recherches en toute confiance.
Les noms alternatifs de DYRK2 sont DYRK2, CpipJ_CPIJ014802, dyrk2, Dyrk2.
Filtrer les résultats:
61 Résultats
DYRK2
Reactivité: Souris
WB, IHC, ELISA
Hôte: Lapin
Polyclonal
Biotin
DYRK2
Reactivité: Souris
WB, IHC, ELISA
Hôte: Lapin
Polyclonal
HRP
DYRK2
Reactivité: Humain
WB, IHC, ELISA
Hôte: Lapin
Polyclonal
HRP
DYRK2
Reactivité: Souris
WB, IHC, ELISA
Hôte: Lapin
Polyclonal
FITC
DYRK2
Reactivité: Humain
WB, IHC, ELISA
Hôte: Lapin
Polyclonal
FITC
DYRK2
Reactivité: Humain
WB, ELISA, IF, ICC
Hôte: Lapin
Polyclonal
unconjugated
DYRK2
Reactivité: Humain, Souris
WB, ELISA
Hôte: Lapin
Polyclonal
unconjugated
DYRK2
Reactivité: Humain, Souris, Rat, Boeuf (Vache), Chien, Cobaye, Cheval, Lapin, Poisson zèbre (Danio rerio), Porc, Roussette (Chauve-souris), Poulet, Singe, Xenopus laevis
WB
Hôte: Lapin
Polyclonal
unconjugated
DYRK2
Reactivité: Humain, Souris
WB, IHC, IHC (p)
Hôte: Lapin
Polyclonal
unconjugated
DYRK2
Reactivité: Humain
WB, IHC (p), IF (cc), IF (p), IHC (fro)
Hôte: Lapin
Polyclonal
unconjugated
DYRK2
Reactivité: Humain
WB, IF (cc), IF (p)
Hôte: Lapin
Polyclonal
AbBy Fluor® 350
DYRK2
Reactivité: Humain
WB, IF (cc), IF (p)
Hôte: Lapin
Polyclonal
AbBy Fluor® 750
DYRK2
Reactivité: Humain
WB, IHC (p), IHC (fro)
Hôte: Lapin
Polyclonal
Biotin
DYRK2
Reactivité: Humain
WB, IF (cc), IF (p)
Hôte: Lapin
Polyclonal
FITC
DYRK2
Reactivité: Humain
WB, IHC (p), IHC (fro)
Hôte: Lapin
Polyclonal
HRP
DYRK2
Reactivité: Humain
WB, IF (cc), IF (p)
Hôte: Lapin
Polyclonal
AbBy Fluor® 594
DYRK2
Reactivité: Humain
WB, IF (cc), IF (p)
Hôte: Lapin
Polyclonal
AbBy Fluor® 647
DYRK2
Reactivité: Humain
WB, IF (cc), IF (p)
Hôte: Lapin
Polyclonal
AbBy Fluor® 488
DYRK2
Reactivité: Humain
WB, IF (cc), IF (p)
Hôte: Lapin
Polyclonal
AbBy Fluor® 555
DYRK2
Reactivité: Humain
WB, IF (cc), IF (p)
Hôte: Lapin
Polyclonal
Cy5
Dernières publications pour nos DYRK2 Anticorps
: "Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer." dans: Oncogene, Vol. 36, Issue 13, pp. 1862-1872, (2017) (PubMed).
: "Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy." dans: BMC urology, Vol. 15, pp. 53, (2015) (PubMed).
: "The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer." dans: PLoS ONE, Vol. 10, Issue 11, pp. e0143376, (2015) (PubMed).
: "Downregulation of DYRK2 can be a predictor of recurrence in early stage breast cancer." dans: Tumour biology, Vol. 35, Issue 11, pp. 11021-5, (2014) (PubMed).
: "DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells." dans: The Journal of clinical investigation, Vol. 122, Issue 3, pp. 859-72, (2012) (PubMed).
: "Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways." dans: Journal of molecular cell biology, Vol. 4, Issue 5, pp. 316-30, (2012) (PubMed).
: "Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma." dans: The Journal of thoracic and cardiovascular surgery, Vol. 138, Issue 6, pp. 1303-8, (2009) (PubMed).
: "DYRK2 expression may be a predictive marker for chemotherapy in non-small cell lung cancer." dans: Anticancer research, Vol. 29, Issue 7, pp. 2753-7, (2009) (PubMed).
: "Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling." dans: Cell, Vol. 133, Issue 3, pp. 537-48, (2008) (PubMed).
: "DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage." dans: Molecular cell, Vol. 25, Issue 5, pp. 725-38, (2007) (PubMed).
: "Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy." dans: BMC urology, Vol. 15, pp. 53, (2015) (PubMed).
: "The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer." dans: PLoS ONE, Vol. 10, Issue 11, pp. e0143376, (2015) (PubMed).
: "Downregulation of DYRK2 can be a predictor of recurrence in early stage breast cancer." dans: Tumour biology, Vol. 35, Issue 11, pp. 11021-5, (2014) (PubMed).
: "DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells." dans: The Journal of clinical investigation, Vol. 122, Issue 3, pp. 859-72, (2012) (PubMed).
: "Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways." dans: Journal of molecular cell biology, Vol. 4, Issue 5, pp. 316-30, (2012) (PubMed).
: "Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma." dans: The Journal of thoracic and cardiovascular surgery, Vol. 138, Issue 6, pp. 1303-8, (2009) (PubMed).
: "DYRK2 expression may be a predictive marker for chemotherapy in non-small cell lung cancer." dans: Anticancer research, Vol. 29, Issue 7, pp. 2753-7, (2009) (PubMed).
: "Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling." dans: Cell, Vol. 133, Issue 3, pp. 537-48, (2008) (PubMed).
: "DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage." dans: Molecular cell, Vol. 25, Issue 5, pp. 725-38, (2007) (PubMed).
Pseudonymes pour DYRK2 Anticorps
dual specificity tyrosine phosphorylation regulated kinase 2 (DYRK2) Anticorpsdual specificity tyrosine-phosphorylation-regulated kinase 2 (CpipJ_CPIJ014802) Anticorps
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (dyrk2) Anticorps
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (Dyrk2) Anticorps
dual specificity tyrosine phosphorylation regulated kinase 2 (Dyrk2) Anticorps
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) Anticorps
1810038L18Rik Anticorps
DYRK2 Anticorps
fc18c09 Anticorps
si:ch211-266a5.8 Anticorps
wu:fa09g03 Anticorps
wu:fc18c09 Anticorps
Avez-vous cherché autre chose?
- DYRK1B Anticorps
- DYRK1A Anticorps
- DYNLT3 Anticorps
- DYNLT1 Anticorps
- DYNLRB2 Anticorps
- DYNLRB1 Anticorps
- DYNLL2 Anticorps
- DYNLL1 Anticorps
- Dynein, Axonemal, Light Chain 4 Anticorps
- DYNC2LI1 Anticorps
- DYNC2H1 Anticorps
- DYNC1LI2 Anticorps
- DYNC1LI1 Anticorps
- DYNC1I2 Anticorps
- DYNC1I1 Anticorps
- DYNC1H1 Anticorps
- Dynamitin Anticorps
- Dynamin 3 Anticorps
- Dynamin 1-Like Anticorps
- Dynamin 1 Anticorps
- DYRK3 Anticorps
- DYRK4 Anticorps
- Dysferlin Anticorps
- Dystonin Anticorps
- Dystrobrevin beta Anticorps
- Dystrobrevin Binding Protein 1 Anticorps
- Dystroglycan Anticorps
- Dystrophin Anticorps
- DYX1C1 Anticorps
- DZANK1 Anticorps
- DZIP1 Anticorps
- DZIP3 Anticorps
- E-cadherin Anticorps
- E2F1 Anticorps
- E2F2 Anticorps
- E2F3 Anticorps
- E2F4 Anticorps
- E2F4/E2F5 Anticorps
- E2F5 Anticorps
- E2F6 Anticorps
Vous êtes ici:
